Bessemer Group’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $869K | Buy |
8,990
+49
| +0.5% | +$5.03K | ﹤0.01% | 975 |
|
|
2025
Q4 | $949K | Sell |
8,941
-74
| -0.8% | -$8.58K | ﹤0.01% | 970 |
|
|
2025
Q3 | $1.15M | Sell |
9,015
-538
| -6% | -$64K | ﹤0.01% | 617 |
|
|
2025
Q2 | $1.17M | Sell |
9,553
-8,005
| -46% | -$914K | ﹤0.01% | 593 |
|
|
2025
Q1 | $1.78M | Sell |
17,558
-23,537
| -57% | -$2.3M | ﹤0.01% | 512 |
|
|
2024
Q4 | $3.8M | Sell |
41,095
-3,645
| -8% | -$358K | 0.01% | 480 |
|
|
2024
Q3 | $4.32M | Buy |
44,740
+33,694
| +305% | +$3.03M | 0.01% | 459 |
|
|
2024
Q2 | $947K | Sell |
11,046
-344
| -3% | -$28.9K | ﹤0.01% | 668 |
|
|
2024
Q1 | $941K | Sell |
11,390
-6,478
| -36% | -$474K | ﹤0.01% | 684 |
|
|
2023
Q4 | $1.19M | Sell |
17,868
-298
| -2% | -$19.3K | ﹤0.01% | 609 |
|
|
2023
Q3 | $1.22M | Buy |
18,166
+22
| +0.1% | +$1.51K | ﹤0.01% | 573 |
|
|
2023
Q2 | $1.23M | Buy |
18,144
+7,397
| +69% | +$464K | ﹤0.01% | 588 |
|
|
2023
Q1 | $581K | Buy |
10,747
+4,245
| +65% | +$247K | ﹤0.01% | 696 |
|
|
2022
Q4 | $389K | Sell |
6,502
-613
| -9% | -$33.3K | ﹤0.01% | 774 |
|
|
2022
Q3 | $322K | Sell |
7,115
-1,846
| -21% | -$92.3K | ﹤0.01% | 815 |
|
|
2022
Q2 | $399K | Buy |
8,961
+364
| +4% | +$18.7K | ﹤0.01% | 756 |
|
|
2022
Q1 | $486K | Buy |
8,597
+2,479
| +41% | +$129K | ﹤0.01% | 648 |
|
|
2021
Q4 | $318K | Buy |
6,118
+1,970
| +47% | +$102K | ﹤0.01% | 744 |
|
|
2021
Q3 | $248K | Buy |
4,148
+170
| +4% | +$10.7K | ﹤0.01% | 724 |
|
|
2021
Q2 | $247K | Hold |
3,978
| – | – | ﹤0.01% | 746 |
|
|
2021
Q1 | $259K | Sell |
3,978
-120
| -3% | -$7.83K | ﹤0.01% | 701 |
|
|
2020
Q4 | $270K | Buy |
4,098
+543
| +15% | +$31.9K | ﹤0.01% | 673 |
|
|
2020
Q3 | $184K | Sell |
3,555
-46,382
| -93% | -$2.38M | ﹤0.01% | 745 |
|
|
2020
Q2 | $2.46M | Buy |
49,937
+15,872
| +47% | +$856K | 0.01% | 433 |
|
|
2020
Q1 | $1.74M | Hold |
34,065
| – | – | 0.01% | 464 |
|
|
2019
Q4 | $1.88M | Sell |
34,065
-1,005
| -3% | -$54.5K | 0.01% | 582 |
|
|
2019
Q3 | $1.77M | Hold |
35,070
| – | – | 0.01% | 548 |
|
|
2019
Q2 | $1.77M | Buy |
35,070
+881
| +3% | +$42.8K | 0.01% | 569 |
|
|
2019
Q1 | $1.59M | Sell |
34,189
-640
| -2% | -$32.4K | 0.01% | 522 |
|
|
2018
Q4 | $1.71M | Sell |
34,829
-881
| -2% | -$50.1K | 0.01% | 434 |
|
|
2018
Q3 | $2.21M | Sell |
35,710
-10,182
| -22% | -$619K | 0.01% | 376 |
|
|
2018
Q2 | $2.47M | Buy |
+45,892
| New | +$2.29M | 0.01% | 355 |
|
|
2018
Q1 | – | Sell |
-55,948
| Closed | -$2.2M | – | 1719 |
|
|
2017
Q4 | $2.2M | Sell |
55,948
-20,489
| -27% | -$779K | 0.01% | 380 |
|
|
2017
Q3 | $2.82M | Buy |
76,437
+514
| +0.7% | +$18.3K | 0.01% | 364 |
|
|
2017
Q2 | $2.92M | Hold |
75,923
| – | – | 0.01% | 363 |
|
|
2017
Q1 | $2.59M | Buy |
75,923
+3,681
| +5% | +$121K | 0.01% | 427 |
|
|
2016
Q4 | $2.37M | Buy |
72,242
+970
| +1% | +$31.5K | 0.01% | 468 |
|
|
2016
Q3 | $2.3M | Buy |
+71,272
| New | +$2.31M | 0.01% | 397 |
|
|
2014
Q4 | – | Sell |
-20,121
| Closed | -$591K | – | 1497 |
|
|
2014
Q3 | $591K | Hold |
20,121
| – | – | ﹤0.01% | 556 |
|
|
2014
Q2 | $574K | Hold |
20,121
| – | – | ﹤0.01% | 547 |
|
|
2014
Q1 | $575K | Hold |
20,121
| – | – | ﹤0.01% | 520 |
|
|
2013
Q4 | $533K | Hold |
20,121
| – | – | ﹤0.01% | 535 |
|
|
2013
Q3 | $552K | Buy |
+20,121
| New | +$517K | ﹤0.01% | 520 |
|
Other funds holding EHC
VPM
VCM
Bessemer Group's EHC Position: Q1 2026 in Review
Bessemer Group increased its Encompass Health (EHC) stake by 0.55% in Q1 2026, buying an estimated $5.03K and bringing the position to 8,990 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #975.
Bessemer Group first reported a position in EHC in Q3 2013 and has held it in 43 quarters since. The position peaked at $4.32M in Q3 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Bessemer Group held 8,990 shares of Encompass Health worth $869K as of Q1 2026.
- Bessemer Group bought 49 Encompass Health shares in Q1 2026, an estimated $5.03K.
- Encompass Health made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #975 holding.
- Bessemer Group first reported a position in Encompass Health in Q3 2013 and has held it in 43 quarters since.
- Bessemer Group's Encompass Health position peaked at $4.32M in Q3 2024.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.